Discover the future of drug discovery and development with an exciting webinar on a novel automated workflow for drug safety and efficacy studies using patient-derived 3D tumor models. 📅 May 29 | 8am PDT / 11am EDT / 5pm CET 📍 Register here: proteinfluidics.com/webinar-may-29…

Are you tired of manual media exchange and frustrated by the variance in results due to changes in performance? Discover the TiltStation by Qinstruments. A unique lab automation device for liquid handlers to automate cell culture applications. Learn more youtube.com/watch?v=X2MP2_…

🔬Join us as we showcase cutting-edge technologies from the BICO group at SLAS (Society for Laboratory Automation and Screening) in Barcelona, Spain. 🚀

What an incredible week it's been! From SLAS to the World Biomaterial Congress, we've had the privilege of witnessing remarkable advancements in biomaterials research and lab automation. 🤖🔬 Looking forward to meeting you all again soon!

The BIONOVA X from CELLINK is the world's first DLP 3D bioprinter that can handle such a wide variety of biomaterials and living cells. It enables effortless modeling of microarchitecture, vasculature, and complex geometries directly onto multi-well plates.

Today we are thrilled to welcome Anders Fogelberg as our Chief Commercial Officer. Commercial excellence has been defined as one of our top strategic priorities and Anders will be pivotal in setting and driving the strategy towards that target. #BICO #commercialexcellence

Andréas Joersjö has been appointed as General Counsel, and we look forward to welcoming him to our Executive Management. Andréas will join BICO by mid-October at the latest. Read the press release: bico.com/single-press-r…

Welcome to BICO’s Capital Markets Day on September 17, 2024! Tune in for the launch of the Group’s updated strategy 2.0 and take a deep dive into the field of lab automation. Register via this link: ir.financialhearings.com/bico-capital-m…. #BICO #Strategy2.0 #CMD2024 #LabAutomation

The BICO Group Q2 2024 interim report is live! Tune into the earnings call at 10 a.m. CEST presented by CEO and President Maria Forss and CFO Jacob Thordenberg with updates and comments of the development in the BICO Group. bico.com/investors

BICO 2.0, our updated strategy, will launch into the world on September 17! Tune in to the online portion of the Capital Markets Day and be among the first to learn more. Register here: bico.com/cmd2024 #BICO #Strategy2.0 #CMD2024 #LabAutomation

Ever wondered what lab automation is all about? Tune in on September 17 for BICO’s Capital Markets Day! Ryan Bernhardt, CEO Biosero, and Derrick Miyao, VP of Molecular Foundry DeepCure, will take you on a deep dive into the field of lab automation.

BICO's Capital Markets Day is less than one week away! We look forward to welcoming you all on September 17 from 1-4 pm CEST for the launch of BICO’s updated strategy 2.0 and a deep dive into the field of lab automation. Register here: bico.com/cmd2024/

Welcome to join us today for BICO’s Capital Markets Day! We are looking forward to see you all online later today at 1pm CEST. Register here: bico.com/cmd2024 #BICO #Strategy2.0 #CMD2024 #LabAutomation #Q&A #MariaForss #EMT

Thank you to everyone who participated in our CMD. If you missed out, you can watch the livestream on demand here: bico.com/cmd2024/ Tune in and listen to the updated strategy and our journey to enable and automate the life science lab of the future. #BICO #CMD2024

Today we are happy to welcome Andreas Joersjö as our General Counsel. Andreas will be a great contribution with his 15+ years of experience working in an international business environment as General Counsel, lawyer, and advisor. #newGC #lifesciencelabofthefuture #BICO

The BICO Group Q3 2024 interim report is live!  Tune into the earnings call at 10 a.m. CET presented by CEO and President Maria Forss and CFO Jacob Thordenberg for a deep dive into the quarter and comments of the development in the BICO Group. bico.com/investors

🎄✨ Happy Holidays from all of us in the BICO family! ✨🎄 As we begin rounding out another wonderful year, we want to thank the entire life science community for another year of constant innovations and the pushing of boundaries.

BICO kicks off 2025 with our President & CEO Maria Forss and our CFO Jacob Thordenberg attending the annual J.P. Morgan Healthcare Conference in San Francisco between January 13-16, 2025. Maria Forss will be presenting on January 15, 3:45pm PST, at the Westin St. Francis. #JPM2025

SLAS is 2 weeks away! Visit us at booths #1330 & #1342 to see an integrated workcell by Biosero ft. Cellenion @CYTENA DISPENDIX & QINSTRUMENTS. Don't miss our panels & presentations as we showcase the future of lab automation. See you there! #BICO #LabAutomation #SLAS2025

The BICO Group’s Year-end report 2024 is live!  Tune into the earnings call at 10 a.m. CET presented by CEO and President Maria Forss and CFO Jacob Thordenberg. The interim report, link to earnings call, and presentation are available here:  bico.com/investors